Value Bridge — BRONXCARE HEALTH SYSTEM
Current $26M → Target $46M (+$19.2M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$26.5M
Current EBITDA
$45.7M
Target EBITDA
+$19.2M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$4.4M
Payer Mix Optimization
$10.4M
Cost to Collect Reduction
$3.5M
Clean Claim Improvement
$2.6M
Volume & Rate Growth
$17.4M
What This Means
The 7-lever model projects a 73% EBITDA uplift from $26M to $46M. The highest-impact lever is Volume & Rate Growth at $7.0M probability-weighted.
IC talking point: "We see $19M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $212M in equity value creation."